近5年高被引文献
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
article
Full Text
OpenAlex
2836
FWCI421.2467
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
article
Full Text
OpenAlex
1666
FWCI430.9726
The hallmarks of cancer metabolism: Still emerging
article
Full Text
OpenAlex
1418
FWCI103.2113
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
article
Full Text
OpenAlex
1028
FWCI106.6958
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
review
Full Text
OpenAlex
1001
FWCI54.0348
New insights into activation and function of the AMPK
article
Full Text
OpenAlex
995
FWCI61.9188
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
article
Full Text
OpenAlex
994
FWCI90.8983
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
article
Full Text
OpenAlex
909
FWCI83.8562
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
article
Full Text
OpenAlex
901
FWCI233.077
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
article
Full Text
OpenAlex
822
FWCI80.8681